Tactical Medicine News Blog
Crean la primera sangre artificial para salvar miles de vidas en zonas de guerra o catástrofes
Posted by EMS Solutions International on
Crean la primera sangre artificial para salvar miles de vidas en zonas de guerra o catástrofesPor favor comparte nuestras redes Grupo Biblioteca/PDFs gratis en Facebook https://www.facebook.com/groups/PDFgratisMedicina #DrRamonReyesMD Facebook https://www.facebook.com/DrRamonReyesMD https://www.facebook.com/EMSSINT https://www.facebook.com/TACMEDEspana/ Instagram https://www.instagram.com/drramonreye...
ACS TQIP Massive Transfusion in Trauma Guidelines pdf by American College of Surgeon
Posted by Dr Ramon REYES, MD on
ACS TQIP Massive Transfusion in Trauma Guidelines pdf by American College of Surgeon Por favor comparte nuestras redes Grupo Biblioteca/PDFs gratis en Facebook https://www.facebook.com/groups/PDFgratisMedicina #DrRamonReyesMD Facebook https://www.facebook.com/DrRamonReyesMD https://www.facebook.com/EMSSINT https://www.facebook.com/TACMEDEspana/ Instagram https://www.instagram.com/drramonreyesmd/ Pintere...
CRISPR-Equipped Bacteria Detect Tumors
Posted by Conn Hastings on
Researchers at the University of California San Diego have created a bacterial sentinel system that can alert clinicians to the presence of tumors. The technology takes advantage of the specificity of the CRISPR system and the tendency of bacteria to uptake fragments of DNA from their environment. Termed “Cellular Assay for Targeted CRISPR-discriminated Horizontal gene […]
Device for Rapid COVID-19 Breath Testing
Posted by Conn Hastings on
Researchers at Washington University School of Medicine have developed a COVID-19 breathalyzer test. The technology requires someone to breathe into it just once or twice, and it can then provide an indication if the person is infected with SARS-CoV-2 in as little as one minute. The device could be very useful fo screening large numbers […]
Unpacking the PEACH Trial: What is Levetiracetam’s Role in Spontaneous Intracerebral Hemorrhage?
Posted by Marco Torres on
BACKGROUND: intracerebral hemorrhage (ICH) makes up 10-15% of all strokes and significantly contributes to overall stroke-related morbidity and mortality (Hostettler 2019). Levetiracetam is frequently used to prevent seizures in patients with conditions such as ICH, traumatic brain injury (TBI), supratentorial neurosurgery, and subarachnoid hemorrhage (SAH). However, guidelines offer no strong recommendations for its use, specifically in spontaneous ICH (Fang 2021). Ongoing debates persist regarding the drug’s effectiveness, optimal dosage, and potential side effects. About 30% of patients experience early seizures within seven days following the onset of a stroke (Peter-Derex 2022). While clinical seizures are readily identifiable, subclinical seizures—which comprise most seizures after a hemorrhage—are hard to detect. The long-term impact of these subclinical seizures is still unclear. More research is needed to inform preventive treatment strategies for seizures in patients with spontaneous intracerebral hemorrhage (ICH).